A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts

Investor logo
Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Science. Official publication website can be found on muni.cz.
Authors

ONDROUŠKOVÁ Eva POVOLNÁ Karolína VÁŇA Petr BENEŠ Petr KONEČNÁ Hana ZDRÁHAL Zbyněk ŠMARDA Jan

Year of publication 2007
Type Article in Periodical
Magazine / Source Leukemia Research
MU Faculty or unit

Faculty of Science

Citation
Field Genetics and molecular biology
Keywords v-myb; monoblast; macrophage; differentiation; proteome; two-dimensional gel electrophoresis; trichostatin A; TPA; mass spectrometry
Description v-myb-oncogene of avian myeloblastosis virus transforms myelomonocytic cells in vitro and induces acute monoblastic leukemia in vivo. The transforming effect of the v-myb can be suppressed using phorbol ester (TPA) or histone deacetylase inhibitor trichostatin A (TSA), the inducers of cell differentiation that are in clinical trials. In this study, we used proteomics-based approach to identify proteins with variable expression in differentiated BM2 cells. Proteome variations induced by TPA and TSA were compared to examine the mechanism of differentiation-promoting effects of these drugs. We found that expression of several proteins participating in cell cytoskeleton rearrangement, heat shock response, proteosynthesis and cell signaling was altered in TPA- or TSA-treated cells. We present here the first comparative proteome analysis of v-myb-transformed monoblasts BM2 focused on identification of proteins involved in their terminal differentiation.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.